SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 20.33 |
| Enterprise Value ($M) | 4.18 |
| Book Value ($M) | 12.27 |
| Book Value / Share | 0.20 |
| Price / Book | 1.66 |
| NCAV ($M) | 11.64 |
| NCAV / Share | 0.19 |
| Price / NCAV | 1.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.56 |
| Return on Assets (ROA) | -0.86 |
| Return on Equity (ROE) | -1.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.09 |
| Current Ratio | 2.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 22.87 |
| Assets | 23.50 |
| Liabilities | 11.23 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -53.97 |
| Net Income | -33.97 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -28.47 |
| Cash from Investing | -0.00 |
| Cash from Financing | 23.57 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Pathstone Family Office, Llc | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 533,315 | 1,313,238 | 40.61 | |
| 1,041,174 | 2,360,083 | 44.12 | |
| 601,082 | 1,925,030 | 31.22 | |
| 288,975 | 860,857 | 33.57 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CELU – Celularity Inc. | CELZ – Creative Medical Technology Holdings, Inc. |
| CGEN – Compugen Ltd. | CING – Cingulate Inc. |
| CKPT – Checkpoint Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io